Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04529252 · ClinicalTrials.gov registry record
Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases
A clinical trial of Cerebellar Ataxia and Spinocerebellar Ataxias, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT04529252: Recruiting study of Cerebellar Ataxia and Spinocerebellar Ataxias, sponsored by Mayo Clinic.
NCT04529252 is a study of Cerebellar Ataxia and Spinocerebellar Ataxias that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 1,000 participants, above the 151-participant average among 5 other Cerebellar Ataxia trials with a reported enrollment target (562% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04529252, a study of Cerebellar Ataxia and Spinocerebellar Ataxias, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to create a repository for cerebellar ataxia and nucleotide repeat diseases in order to fully investigate the genetic and phenotypic presentations of both.
Primary Outcome
Specimen sample collection to create a repository for genetic neurodegenerative forms of spinocerebellar ataxia and nucleotide repeat diseases not including Huntington's disease
Conditions Studied
Interventions
- OTHER Specimen collection
Study Locations (1)
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2017-07-17 |
| Est. Completion | 2026-12 |
What NCT04529252 shows while recruiting
NCT04529252 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 151-participant average among 5 other Cerebellar Ataxia trials with a reported enrollment target (562% higher).
The record links to 3 conditions, with Cerebellar Ataxia appearing as the primary indexed condition, and to 1 intervention - of which Specimen collection is the first listed.
NCT04529252 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04529252 about?
NCT04529252 is a clinical study titled "Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases". The purpose of this study is to create a repository for cerebellar ataxia and nucleotide repeat diseases in order to fully investigate the genetic and phenotypic presentations of both.
What is the current status of trial NCT04529252?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2017-07-17. Estimated completion is 2026-12.
What conditions does trial NCT04529252 study?
This clinical trial studies the following conditions: Cerebellar Ataxia, Spinocerebellar Ataxias, Nucleotide Repeat Disease.
What interventions are being tested in trial NCT04529252?
The interventions under investigation include: Specimen collection (OTHER).
Who is sponsoring clinical trial NCT04529252?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04529252 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebellar Ataxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Home Exercise for Individuals with Neurodegenerative Disease
RECRUITING · NA
-
Retraining Reaching in Cerebellar Ataxia
RECRUITING · NA
-
Promoting Physical Activity Engagement for People With Early-stage Cerebellar Ataxia
ACTIVE NOT RECRUITING · Phase 1
-
Motor Learning After Cerebellar Damage: The Role of the Primary Motor Cortex
ACTIVE NOT RECRUITING · NA
-
The Role of Cerebellum in Speech
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI